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Background. Pregnancy-related low back pain and pelvic girdle pain (LBP/PGP) are common and 
negatively impact the lives of many pregnant women. Several patient-based outcome instruments 
measure treatment effect but there is no consensus about which measure to use with women who have 
these pain presentations.  
Objective. The objective was to compare the responsiveness of 3 outcome measures in LBP/PGP: 
Oswestry Disability Index-version 2.0 (ODI), Pelvic Girdle Questionnaire (PGQ), and 0-10 numerical 
rating scale for pain severity (NRS); and to estimate a minimal important change (MIC) for these 
measures in pregnancy-related LBP/PGP. 
Design. This was a methodology study using data from a pilot randomised trial (RCT).  
Methods. Women (n = 124) with pregnancy-related LBP/PGP were recruited to a pilot RCT 
evaluating the benefit of adding acupuncture to standard care and 90 completed 8-weeks follow-up. 
Responsiveness was evaluated by examining correlation between change score and the external anchor 
(6-point global perceived effect scale) and by using receiver operating characteristic (ROC) curve 
analysis. MIC was estimated using anchor-based methods.  
Results. All measures showed good responsiveness, with areas under ROC curve ranging from 0.77 to 
0.90. The estimated MICs were 3.1, 11.0, 9.4, 13.3, and 1.3 for ODI, PGQ-total, PGQ-activity, PGQ-
symptoms, and NRS, respectively. All the measures, apart from ODI, had MICs larger than the 
measurement error.  
Limitations. Lack of optimal “gold standard” or external criterion for assessing responsiveness and 
MIC was a limitation of this study.   
Conclusion. All 3 outcome measures demonstrated good responsiveness. MICs were derived for each 
instrument. The PGQ at 8 weeks post-randomisation was identified as an appropriate outcome measure 
for pregnancy-related LBP/PGP since it is specific to these pain presentations and assesses both 
activity limitations and symptoms. The NRS is an efficient, shorter alternative. 
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Pregnancy-related low back pain (LBP) and pelvic girdle pain (PGP) are common conditions1,2 and 
impact, both socially and economically, the daily lives of many pregnant women.3 The incidence and 
point prevalence of pregnancy-related LBP and PGP reported in literature vary, partly because there is 
a variation in the criteria employed by various studies for the diagnosis of these conditions and the 
designs of the studies, but estimates range from 24% to 90% of women experiencing LBP or PGP at 
some stage during their pregnancy.1,4-6 The two pain presentations may occur separately or together 
and typically increase with advancing pregnancy.2  
Treatment of pregnancy-related LBP and PGP is often aimed at reducing the pain and improving 
function. Therefore, assessing whether pain or function has changed over time is a vital objective of 
measurements in clinical practice and health research. Outcome measures for LBP and for the 
disability caused by LBP have become important standards for evaluation of interventions due to their 
frequent use in the assessment of the effectiveness of treatments.7 There have been several consensus 
developing initiatives to agree on core outcome domains and core outcome measures for non-specific 
LBP,7,8 however, there is a lack of consensus on what measure to use for pregnancy-related LBP and 
PGP as outcome measures that have been validated for non-specific LBP are not necessarily the most 
appropriate for pregnancy-related LBP and PGP.9 There is therefore a need for a direct comparison 
between LBP outcome measures in order to inform the choice of the most appropriate outcome 
measure to use in pregnancy-related LBP and PGP.  
An important measurement property of a patient reported outcome measure (PROM) is its ability to 
detect clinical change over time. This can be evaluated by determining the responsiveness of the 
PROM, defined as the ability of an instrument to detect change over time in the construct to be 
measured.10 A related question of interest is whether the observed changes within patients are 
clinically relevant. This can be evaluated by determining the minimal important change (MIC), 
defined as the minimal amount of change that is important to the patient.11,12 Analysing the 
responsiveness and MICs of an outcome measure is a continuous process that is strongly 
recommended to strengthen its properties and expand its applicability.13   
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Since two main aims of treatment for pregnancy-related LBP and PGP are to relieve pain and to 
improve functional ability, we included PROMs that are frequently used to capture pain and impact of 
pain on everyday activities (measured using both the Oswestry Disability Index and the Pelvic Girdle 
Questionnaire (PGQ). The responsiveness for the ODI and NRS has been established for the non-
specific LBP population, but not in pregnancy-related LBP or PGP. The Pelvic Girdle Questionnaire 
(PGQ) is a recent outcome measure developed for both pregnant and postpartum women and its 
responsiveness and MIC have been established for women in late pregnancy and transitioning to 
postpartum,14 however, no previous study has established the properties of this instrument entirely 
during the course of pregnancy within a trial context. The previous study14 recruited women in the last 
trimester of their pregnancy and within 3 months after delivery and therefore their assessment of the 
measurement properties are more relevant to the context of natural history or epidemiological cohort 
studies rather than clinical trials of treatment for LBP and PGP during pregnancy. 
In order to aid decision-making about outcome measures for use in clinical trials of treatment 
effectiveness for pregnancy-related LBP and PGP, it is important to determine the responsiveness and 
MICs of the PROMs used to capture pain and impact of pain in women seeking treatment. This can be 
best done by choosing a population of women seeking treatment for pregnancy-related LBP and PGP 
and a time-point during pregnancy in the evaluation of responsiveness and MICs. 
The purpose of this study was twofold: (1) to compare the responsiveness of three PROMs during 
pregnancy in patients with pregnancy-related LBP and PGP: the Oswestry Disability Index-version 2.0 
(ODI), the Pelvic Girdle Questionnaire (PGQ), and a 0-10 numerical rating scale (NRS) for pain 
severity, and (2) to estimate the optimal cut-off values for a MIC for these measures with patients who 
have pregnancy-related LBP and PGP. 
[H1]Methods 
[H2]Study participants  
This study used the data from a three-arm parallel pilot randomised controlled trial (RCT) that 
assessed the feasibility of a future large RCT testing the additional benefit of acupuncture to standard 
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care for pregnancy-related LBP and PGP– the EASE Back pilot trial15 (trial registration 
ISRCTN49955124). Full details of the EASE Back pilot trial are available elsewhere,15,16 including the 
full details of the definitions of LBP and PGP we used. Here we give brief details. The EASE Back 
trial was funded following a commissioned call by the UK’s National Institute for Health Research 
(NIHR) Health Technology Assessment programme, focused on pregnancy-related LBP with or 
without PGP. Women aged 18 years and over were included if they had pregnancy-related LBP 
defined as self-reported pain in the lumbar area (between the 12th  rib and the gluteal fold) with or 
without PGP (defined by pain between the posterior iliac crest and the gluteal fold, particularly in the 
vicinity of the sacro-iliac joints), were under the care of participating NHS sites and GP practices, at 
13 to 31 weeks gestation, were naïve to acupuncture treatment, able to read and communicate in 
English and were willing to participate. Women who had LBP episodes before this pregnancy were 
included as long as the current episode of LBP was either attributed to, or made worse as a result of, 
this pregnancy. Women were excluded if they had previously had any form of acupuncture, were at 
high risk of miscarriage or pre-term labour, had pre-eclampsia, previous history of surgery to the spine 
or pelvis, and had contra-indications to the treatments, pain in the anterior pelvic region only, or a 
current urinary tract infection. Eligible women who gave written informed consent to participate were 
randomised in a 1:1:1 ratio, to one of the three treatment arms: standard care alone (comprehensive 
self-management booklet and an option to access EASE Back physiotherapy care if needed); standard 
care plus a course of true acupuncture; and standard care plus a course of non-penetrating acupuncture, 
delivered by physiotherapists. Ethical approval for the EASE Back pilot trial was granted by NRES 
Committee West Midlands - Staffordshire (reference 13/WM/00).  
[H2]Sample size 
In line with pilot trial recommendations17 no formal sample size calculation was conducted for the 
EASE Back pilot trial for the key clinical outcomes. However, we aimed to recruit a large number of 
patients  to obtain an acceptable number of patients for the responsiveness and MIC analysis based on 
the guidelines for sample sizes in studies on validity and responsiveness.13 A total of 124 pregnant 
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women were randomised and provided baseline data, while 90 also provided data on the three outcome 
measures at 8 weeks follow-up. 
[H2]Data collection 
At baseline, patients completed a questionnaire containing sociodemographic data and PROMs. At 8 
weeks post-randomisation, patients completed the same outcome measures used at baseline assessment 
and a patient’s Global Perceived Effect (GPE) scale for change of the pregnancy-related LBP/PGP and 
disability measured using a 6-point ordinal scale: (1) completely recovered, (2) much improved, (3) 
somewhat improved, (4) same, (5) somewhat worse, and (6) much worse. The decision to collect 
outcome data at 8 weeks post-randomisation was timed to ensure that most women would not yet have 
given birth to their baby. 
[H2]Outcome measures  
The EASE Back pilot trial did not have a primary clinical outcome. Instead, two outcome measures 
capturing data on physical function and one instrument of pain severity were included in the pilot trial, 
in order to help inform the decision about a primary outcome measure for a future main trial. Several 
factors were taken into consideration in examining the performance of these measures. These included 
the amount of missing data at the item and scale levels; precision of the outcome measures; any 
evidence of floor or ceiling effects; their responsiveness to change; and MICs. Evaluation of these 
factors is the focus of this paper. The PROMs used included: 
[H3]Oswestry disability index (ODI), version 2.0 
The ODI18,19 is a self-administered questionnaire containing 10 sections, each containing six 
statements that are scored from 0 to 5, with 0 representing no difficulty in the activity and 5 
representing maximal difficulty. The scores from each section are totalled and divided by the total 
possible score to obtain a final percentage of disability, with a higher percent indicating greater 
disability. Decreasing scores for the ODI over time denote improvement. The ODI is a valid, reliable, 
and responsive clinical tool for analysing disability status in individuals with LBP.20  
[H3]Pelvic Girdle Questionnaire (PGQ) 
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The PGQ is a validated tool that captures self-reported pain and disability specifically for pregnant and 
post-partum women.21,22 It has two subscales capturing activity limitations and symptoms. Items are 
scored on a 4-point descriptive scale, and item scores are summed and transformed to yield a score of 
0 to 100, where 100 is the worst possible score. The PGQ has been shown to have acceptable 
responsiveness in women with PGP, LBP, or both.14 
[H3]Numerical rating scale (NRS) for pain 
The NRS asks patients to rate their pain severity on an 11-point scale where 0 indicates no pain and 10 
indicates worst imaginable pain. Pain severity was measured using the mean of three 0 to 10 NRS for 
least, usual and current pain over the previous 2 weeks.23 
[H2]Analysis 
All analyses were performed using Stata version-14.24 For a better comparison of the measures with 
differing scoring intervals, all scales were transformed to cover an interval ranging from 0–100. 
Change in scores was obtained by subtracting the 8 week follow-up scores from the baseline 
scores. Descriptive statistics (mean and standard deviations (SDs) or frequencies and percentages, as 
appropriate) were used to summarise the characteristics of participants who returned questionnaires at 
baseline and those who returned both baseline and follow-up questionnaires and to summarise the 
distribution of the change scores for the different outcomes according to whether the patients were 
classified as improved. Box plots were used to visualise the distribution of change score by the 
categories of GPE scale.  The proportion of missing data at the item and scale level was computed. 
Since the percentage of missing (or not applicable) data for the questionnaire items was very minimal, 
the scores were recalculated as a percentage of the remaining items whenever an item was missing as 
recommended by the questionnaire developers; hence all the participants followed up had a score on 
all the instruments.  Floor and ceiling effects were considered present if more than 15% of 
respondents achieved the lowest or highest possible score, respectively.25  
The precision of the measures was evaluated using standard error of measurement (SEM),26,27  
calculated as SD�(1 − 𝑟𝑟)28, where SD is the standard deviation of the baseline scores and r is the 
test-retest reliability coefficient obtained from a previous similar study.22 The minimum detectable 
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change (MDC), defined as the lowest change, for an individual, that exceeds measurement error and 
noise at a 95% confidence level was calculated as 1.96*√2*SEM=2.77*SEM.28 
[H2]Responsiveness 
Due to variations in method of assessing responsiveness, we adhere to the COnsensus based Standards 
for the selection of health Measurement Instruments (COSMIN)10 recommendations in this paper. 
First, we determined the correlation between the change score and the rank of the self-rated GPE scale 
using Spearman’s coefficient, where we hypothesised that there would be moderate-to-high 
correlations between change score and the GPE scale if they measure the same construct.  Second, we 
used a receiver operating characteristic (ROC) curve analysis to plot the sensitivity versus 1-specificity 
for multiple cut-off points of the outcome measures against the external criterion. In the absence of a 
gold standard, the GPE scale, dichotomised into “improved” (combining categories 1 and 2) and not 
improved (combining categories 3-6) was used as the external criterion since this categorisation has 
been recommended as the optimal cut-off.29 This measure, despite criticisms that it is a retrospective 
measure of change30 and is influenced by current status,31 has been shown to provide reliable 
assessments of health transition in people with musculoskeletal pain.31 An area under the ROC curve 
(AUC) was used to assess the ability of the instruments to discriminate between patients who are 
considered to be improved and patients who are not considered to be improved according to the 
external criterion.32  
[H2]MIC  
The MIC was assessed using the anchor based approach to give an indication of the importance of the 
observed change by participating women. We used the ROC curve analysis where each instrument was 
considered as the diagnostic test, and the anchor as the gold standard, to distinguish patients with 
important improvement from patients with no important change.33 We calculated sensitivity and 
specificity for each possible cut-off value of the change score and obtained an ROC curve. The MIC 
was defined as the optimal ROC cut-off point, that is, the change in score that is associated with the 
smallest amount of misclassification.  
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[H2]ROLE OF THE FUNDING SOURCE: The EASE Back study was funded by the National 
Institute for Health Research (NIHR) Health Technology Assessment Programme (HTA) (grant ref. 
no. 10/69/05) and supported by an NIHR Research Professorship to Professor Foster (NIHR-RP-011-
015), who is an NIHR Senior Investigator. The funders played no role in the conduct, analysis, or 
reporting of this study, and the views expressed are those of the authors and not necessarily those of 
the National Health Service, the NIHR, or the UK Department of Health.  
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[H1]Results 
[H2]Baseline characteristics 
A total of 124 pregnant women (mean (SD) age 28 (5.3) years) were randomised and provided 
baseline data and 90 provided follow-up data at 8 weeks for all 3 measures. Characteristics of these 
participants have previously been reported.15 As described in the report, a comparison of key baseline 
characteristics (age and index of multiple deprivations) captured from the anonymised data on women 
who were ineligible or declined participation with the EASE Back trial participants showed that there 
was reasonable overall comparability in these key baseline characteristics, indicating that our study 
sample was generally representative.  Only 14% of participants had given birth by the time they 
returned the 8-weeks follow-up questionnaire. Table 1 shows the characteristics of the participants 
who completed questionnaires at baseline and those who provided data at both baseline and at 8-weeks 
follow-up. The subset of patients at 8-weeks follow-up was similar to the baseline sample in age, 
gestation week, pain location, pain duration, pain severity, and disability scores, but had a higher 
proportion of patients in full/part-time jobs and a slightly higher proportion of patients who were 
married. 
[H2]Missing data, floor and ceiling effect 
There were no missing data for pain severity, but minimal amounts of missing data for the ODI and 
PGQ. The proportion of the questionnaire items with missing data for all participants at baseline was 
2.8% for ODI1 and 6.2% for the PGQ. At follow-up the proportion was 7.8% and 8.7% for the ODI 
and PGQ, respectively. No floor or ceiling effects were shown in any of the measures– the total score 
for ODI ranged from 10% (scored by n=1) to 66% (scored by n=1) while the total PGQ score ranged 
from 13.6 (scored by n=1) to 85.3 (scored by n=1). 
 
 
 
                                                 
1 The percentage is for the item missing data, for example, 35 items were missing out of a total of 1240 ODI scale items for 
the 124 participants. Similarly, there were 191 missing items (6.2%) out of possible 3100 items (25 x 124) for PGQ. 
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[H2]Change score from baseline 
Table 2 shows the mean (SD) change score for improved and unimproved patients for all the three 
outcome measures.  
 
Figure 1 shows the box plots of change scores for categories of GPE. Patients who reported complete 
recovery or much improved showed the highest change in all the measures while those who reported 
worsening showed deterioration on all the measures. Hence, change scores on all the measures 
corresponded to the magnitude of change as rated by patients on the GPE. 
[H2]Responsiveness 
The Spearman’s correlation coefficient between the change score and the GPE scale for each measure 
was moderate to high ranging from 0.59 for PGQ activity subscale to 0.77 for pain severity (Tab. 3). 
All the measures showed good responsiveness (Fig. 2), with AUCs ranging between 0.77 and 0.90, 
indicating that all these measures are responsive over time in this patient population. Pain severity and 
the PGQ-symptoms subscale showed higher AUC compared to other measures. Exploratory subgroup 
analyses of the correlations by trial arms (Supplementary Tab. 1) and gestational weeks 
(Supplementary Tab. 2) showed no major differences between the study arms (especially between the 
standard care and true acupuncture) or gestational weeks, showing that randomisation and gestational 
week had no major effect on the measurement properties. 
 
[H2]SEM, MDC and MIC estimates 
Table 4 presents the SEM, MDC95 values, and the MIC identified by the optimal cut-off change in the 
ROC analysis together with the sensitivity and specificity at the cut-off for each outcome measure. The 
MIC ranged from 3.1 for ODI to 13.3 for pain severity (0–100 scale). When we relate the calculated 
MICs to the imprecision of the outcome measures assessed by the SEM (as we would want the MIC to 
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be at least higher than the SEM), we observe that the obtained MICs were all larger than the SEM 
except for the ODI.  
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[H1]Discussion 
[H2]Summary of findings  
This study provided a head-to-head comparison of the responsiveness of three PROMs, a 0-10 NRS for 
pain severity, the ODI and PGQ, and estimated the MIC for each. We found that all the three outcome 
measures had acceptable responsiveness based on a moderate-to-high correlation with the anchor and 
an AUC of more than 0.7, with NRS having the highest responsiveness, followed by the PGQ-
symptoms subscale. Missing data in the three outcome measures was very minimal. No floor or ceiling 
effects were observed, indicating that the PROMs may be able to distinguish patients with the lowest 
or highest possible score.  
Our study also estimated the MICs for the ODI, PGQ-total score, PGQ-activity subscale, PGQ-
symptom subscale and 0-10 NRS pain severity as 3, 11, 9, 13 and 1.3 points, respectively. This 
indicates that when used at individual level, a change score smaller than these MIC values should be 
regarded as insignificant and only a change above these values can be considered as ‘‘clinically 
relevant’’ change. However, it’s worth noting that the obtained MIC for the ODI was almost the same 
as the SEM value indicating that for this measure there might be a risk that an obtained MIC is an 
expression of the imprecision of the instrument, and not a true change. 
[H2]Comparison with previous studies 
Previous studies have compared the responsiveness of PROMs measuring activity limitations in people 
with non-specific LBP,20,34 however, to the best of our knowledge, only one previous study14 has 
evaluated the responsiveness and MICs of these questionnaires in pregnant women who report PGP. 
Key differences between that previous study14 and our study include: (1) study design – the previous 
study was a prospective cohort of women recruited from maternity centres, compared to our 
randomised trial comparing effectiveness of treatments in women seeking treatment for their 
pregnancy-related LBP and PGP; (2) study population – our study recruited women seeking treatment 
for pregnancy-related LBP and PGP who were between 13 to 31 weeks pregnant whereas Stuge et 
al’s14  study recruited a consecutive sample of women from maternity centres in the last trimester of 
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pregnancy whose status was changing from pregnant to post-partum, irrespective of whether they had 
pain or were seeking treatment for it; and  (3) timing of outcome assessment – our follow-up time-
point was deliberately chosen to capture change in pain and function whilst women were still pregnant, 
whereas Stuge et al’s14  follow-up time-point was post-partum. Hence our study addresses a different 
question than the previous study,14 as we focused on the responsiveness and MIC of the three outcome 
measures in women seeking treatment for pregnancy-related LBP and PGP, we included a different 
population of women and used a time-point during pregnancy in our evaluation of responsiveness and 
MIC. The latter point is important given the relevance to future clinical trials of treatment effectiveness 
of interventions for pregnancy-related LBP and PGP.  
Estimates of MIC have previously been reported for the ODI in non-specific LBP patients29,35 and for 
the ODI and PGQ in pregnant women transitioning to the post-partum period.14 We found the MIC for 
the ODI to be 3.1 points. This value is lower than the MIC values previously reported in the non-
specific LBP literature, where MICs of at least 10 points have been recommended.29 This suggests that 
the ODI might not be a sensitive measure of activity limitations among pregnant women. Our MIC 
values for the PGQ and its subscales were also lower than the ones found for women proceeding from 
being pregnant to post-partum14. These differences in the MIC values may be explained by the fact that 
MIC cannot be considered a fixed property of an outcome measure36 as it depends on the setting of the 
study in which the measure is used. Hence for our study population, an important change for pregnant 
women is not necessarily the same as an important change for the women as they transition from being 
pregnant to after giving birth. For pregnant women, activity limitation is often accepted as a ‘normal’ 
part of pregnancy, therefore, even a small improvement can be clinically meaningful to them, this may 
explain the lower MIC values obtained in our study.  
The MIC value for pain severity measured by the NRS in non-specific LBP has also been previously 
reported in the literature to vary widely from 0.7 to 4 points.29,37,38 However, there are no studies that 
have evaluated the MIC for the NRS for pain severity specifically in pregnant women, so we cannot 
make a direct comparison. Our MIC value for NRS pain severity of 1.3 points falls within the range for 
the general non-specific LBP population suggested by other authors.29,37  
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[H2]Implications 
Despite having many outcome measures with which to assess non-specific LBP, currently there is no 
measure specifically for pregnancy-related LBP and PGP so comparing three measures and 
recommending the most appropriate one provides guidance for the future assessment of these pain 
presentations. The MIC is not a fixed attribute and usually fluctuates based on what is interpreted as 
important to the patient,26 therefore, it is important to derive these values from the population of 
interest. Condition specific outcomes have been shown to have several advantages as they are intended 
to have very relevant content for the specific problem in that population and are therefore more likely 
to detect important changes that occur over time.39 Our findings provide evidence regarding which 
outcome measures to recommend for assessing pain and function in women with pregnancy-related 
LBP and PGP. All the three measures showed acceptable responsiveness in our study. However, the 
MIC for the ODI was of similar magnitude to the measurement error thus questioning its use.  
[H2]Strengths and limitations 
A limitation of this study, which also applies to nearly all the responsiveness and MIC studies,40,41 is 
the lack of a universally accepted methodology to determine responsiveness and MIC, which can result 
in a wide range of reported MIC values for a single outcome measure depending on the methodology 
chosen. However, we have adhered to the COSMIN recommendations which attempt to unify the 
methods for evaluating responsiveness and MIC. A further limitation of our study is the use of the 
GPE scale as the sole external criterion as there is no universally acceptable definition of “minimally 
important” using this anchor; hence our MICs would differ if a different anchor was chosen. However, 
it has been argued that for the GPE scale, the MIC is most appropriately defined in terms of at least 
“much improved” instead of including “somewhat improved,”'29 and this is the approach we took. 
Reassuringly, our results showed that change scores on all three outcome measures corresponded to 
the magnitude of change as perceived by patients. Further limitations of our study involve the 
inclusion of women reporting pain in areas consistent with a presentation of LBP, with or without PGP 
(as this was the population stipulated by the research funder), therefore, it is possible that the findings 
for the PGQ may be different than if we had included a sample of women who had PGP only; 
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however, there is no reliable method to distinguish clearly between these patient groups and in clinical 
practice as in this study, women present with both. 
[H2]Future research 
Since the number of patients who reported being unchanged was small, we relied on the reliability 
parameters from a previous study to calculate the SEM. A future test-retest study with a similar 
population should be carried out in order to confirm our findings. A future study with larger sample 
size could use other anchor based methods such as the mean change method based on patients who 
identify themselves to be ‘‘somewhat improved’’ on the patient-reported GPE scale.  
[H1]Conclusion 
Our analysis, comparing the ODI, PGQ and pain NRS, showed that all three outcome measures were 
responsive to change in women with pregnancy-related LBP and PGP and hence are suitable for 
measuring the effectiveness of treatments; of the three tested, the NRS for pain severity was the most 
responsive. The MIC of the ODI was comparable to its imprecision, hence its utility may be 
questionable.  We identified the PGQ at 8 weeks post-randomisation as an appropriate outcome 
measure for pregnancy-related LBP and PGP. The NRS for pain severity is an efficient, shorter 
alternative. 
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Table 1: Baseline Characteristics of Participants Who Returned Questionnaires at Baseline and 
Those Who Provided Data at Both Baseline and at 8-Weeks Follow-upa 
Baseline Characteristics Participants 
Randomized and 
Providing 
Baseline Data  
(n = 124)  
Participants Returning 
Complete 8-Weeks 
Follow-up Questionnaire 
on All 3 Outcome 
Measures   
(n = 90) 
Age (years), mean (SD) 28.3 (5.3) 29.2 (5.3) 
Highest qualification: degree/postgraduate, n (%) 45 (36.3) 40 (44.4) 
Gestation weeks at inclusion: 24+, n (%) 52 (41.9) 37 (41.1) 
Married, n (%) 54 (43.6) 46 (51.1) 
Working (full-time or part-time), n (%) 87 (70.2) 71 (78.9) 
Pre-pregnancy BMI, n (%)   
Normal/ underweight 47 (39.8) 37 (44.1) 
Overweight 36 (30.5) 27 (32.1) 
Obese/ morbidly obese 35 (29.7) 20 (23.8) 
Pain location (manikin)b, n (%)   
     LBP only 23 (18.6) 17 (18.9) 
     LBP with anterior PGP 18 (14.5) 13 (14.4) 
     LBP with anterior PGP and pain elsewhere 36 (29.0) 22 (24.4) 
     LBP and pain elsewhere 47 (37.9) 38 (42.2) 
Duration of episode: > 6 weeks, n (%) 68 (54.8) 46 (51.1) 
Pain severity (mean of 3 0 - 10 NRS), mean (SD) 4.6 (1.7) 4.3 (1.6) 
Oswestry Disability Index (0 - 100) c, mean (SD) 34.4 (12.9) 32.3 (11.7) 
Pelvic Girdle Questionnaire (0 - 100) d, mean (SD)   
Total 53.3 (17.0) 51.6 (17.1) 
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Activity subscale 51.3 (17.9) 49.9 (18.2) 
Symptom subscale 60.2 (18.4) 57.8 (17.9) 
aLBP = low back pain; BMI = body mass index; PGP = pelvic girdle pain; SD = standard deviation 
bLBP was defined as self-reported pain in the lumbar spine area (between the 12th rib and the gluteal fold); PGP was defined by pain 
between the posterior iliac crest and the gluteal fold, particularly in the vicinity of the sacroiliac joints; Pain elsewhere was pain not in 
the areas described by the definitions of LBP or PGP e.g. pain in the thoracic spine, pain in the shoulder, etc. 
cOswestry Disability Index- has 10 sections with scores ranging from 0 to 5 in each section, item scores are summed and transformed to 
yield a score of 0 to 100 where 100 is the worst possible score.  
dPelvic Girdle Questionnaire- items are scored on a 4-point scale and item scores are summed and transformed to yield a score of 0 to 
100 where 100 is the worst possible score.  
 
 
Table 2: Mean Change Scores (SD) for the 3 Outcome Measures According to Whether They Were 
Classified as Improved or Not Based on Their Answer on the GPE Scale.a 
Key Outcomes Mean (SD) Change Score From Baseline 
 Improved (n = 
44)b Not Improved (n = 46) 
ODI score (0-100) 14.9 (12.2) -3.1 (15.5) 
PGQ (0-100)   
    Total 21.8 (16.2) -0.8 (21.6) 
    Activity subscale 20.1 (16.8) -1.6 (22.9) 
    Symptom subscale 28.3 (19.2) 2.2 (21.0) 
Pain severity (mean of 3 NRS)b 29.9 (15.6) -2.8 (20.5) 
aODI = Oswestry Disability Index; PGQ = Pelvic Girdle Questionnaire; SD = standard deviation 
bAt 8 weeks follow-up, 6 participants (7%) reported complete recovery, 38 (42%) much improved, 17 (19%) 
somewhat improved, 7 (8%) the same, 11 (12%) somewhat worse and 11 (12%) much worse. Hence, 44 
(49%) were classified as improved and 46 (51%) as not improved. 
 
 
Table 3: AUC (With 95% CI), The Spearman Correlation Coefficient Between the Change Score 
and the Rank of the Self-Rated GPE Scale for Each Measure (N=90) and the Median Change Score 
Amongst Patients Who Rated Themselves as “Somewhat Improved”a 
Key Outcomes Correlation 
with GPE 
Scaleb 
AUC (95% CI) Median (IQR) Change Score 
for the “Somewhat Improved” 
GPE Category (n=17) 
ODI score (0-100) -0.67 0.83 (0.74, 0.92) 8.0 (-6.2, 17.1) 
PGQ (0-100)    
    Total -0.62 0.79 (0.70, 0.89) 11.0 (3.9, 29.2) 
    Activity subscale -0.59 0.77 (0.67, 0.87) 8.8 (-1.5, 33.3) 
    Symptom subscale -0.66 0.83 (0.74, 0.92) 13.3 (0.0, 20.0) 
Pain severity (mean of 3 NRS)b -0.77 0.90 (0.84, 0.97) 6.7 (0.0, 20.0) 
aODI = Oswestry Disability Index; PGQ = Pelvic Girdle Questionnaire; GPE = Global Perceived Effect; IQR = interquartile range; AUC = 
area under the curve; CI = confidence interval 
bThe negative sign for the correlation coefficient indicates that an increase in change score (improvement) for each of the measures is 
associated with lower rating (better improvement) on the GPE scale. 
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Table 4: Measurement Error, MDC, and MIC Values for Each of the Three Outcome Measures 
Key Outcome Measures  MIC  
  
ROC SEM MDC
b 
 AUC (95% CI) Optimal 
Cut-Point  
Sensitivity 
and 
Specificity at 
Cut-Point 
  
ODI score (0-100) 0.83 (0.74, 0.92) 3.1  0.89; 0.74 3.1 8.68 
PGQ (0-100)      
    Total 0.80 (0.70, 0.89) 11.0  0.77; 0.74 4.5 12.46 
    Activity subscale 0.77 (0.67, 0.87) 9.4  0.77; 0.72 4.7 13.12 
    Symptom subscale 0.83 (0.74, 0.92) 13.3  0.84; 0.72 5.5 15.29 
Pain severity (mean of 3 NRS) c 0.90 (0.84, 0.97) 13.3  0.87; 0.85 5.2 20.44 
aAUC = area under the curve; CI = confidence interval; MIC = minimal important change; MDC = minimum detectable change ODI = 
Oswestry Disability Index; PGQ = Pelvic Girdle Questionnaire; ROC = receiver operating characteristic; SEM = standard error of 
measurement.  
bThe MDC95 represents the smallest change score that could be said to represent a real change beyond measurement error with 95% 
confidence in one individual. For example, the MDC95 value for ODI indicates that in 95% of the cases, patients will have experienced 
real change (beyond measurement error) if their score has changed by at least 8.68 points on the ODI. 
cThe NRS has been transformed to 0-100 for comparability with other outcome measures.  For SEM computation, a reliability of 0.94 
was used for ODI, 0.9 for pain severity, 0.93 for PGQ total, 0.93 for PGQ-activity and 0.91 for PGQ-symptoms subscales obtained from 
a previous validation study. 
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Figure Legend 
Figure 1: Box plots of the distribution of change scores (baseline minus follow-up) for the different 
outcome measures in relation to categories of GPE scale. ODI = Oswestry Disability Index; PGQ = 
Pelvic Girdle Questionnaire. 
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Figure 2: The receiver operating characteristic (ROC) curves of key outcome measures against 
global perceived effect. AUC = area under the curve; ODI = Oswestry Disability Index; PGQ = 
Pelvic Girdle Questionnaire. 
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